How rare diseases are shaping therapeutic innovation with Jennifer Adair, Claire Booth,Terry Flotte and Donald Kohn
This episode, recorded at the ASGCT 2026 Annual Meeting in Boston, focuses on Molecular Therapy Advances’ upcoming special issue, Beyond prevalance: How rare diseases are reshaping therapeutic innovation. Listen as Editor-in-Chief of Molecular Therapy Advances, Dr. Mohamed Abou-el-Enein, discusses the evolution of therapeutic development for rare diseases with guest editors Drs. Jennifer Adair, Claire Booth, Terence Flotte, and Donald Kohn. Music: 'Electric Dreams' by Scott Buckley - released under CC-BY 4.0. www.scottbuckley.com.auShow your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from ASGCT Podcast Network
Advancements in Pediatric Cancer Therapy with Nirali Shah and Timothy Cripe
From Innovation to Access: Patient Advocacy as a Strategic Partner with Sara Johnson Davis
Using AI to Drive Innovation in CGT with Le Cong, PhD
The biological clock of aging and the possibility of lifespan extension with Christin Glorioso and John Bell
Get summaries like this every morning.
Free AI-powered recaps of ASGCT Podcast Network and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.